Latest News

Date Title Topic
27 Jul 2016 Infection-Associated Cancers Epidemiology/Etiology/Cancer Prevention
26 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Lenvatinib in the Treatment of Unresectable Advanced or Metastatic RCC Genitourinary cancers - Anticancer agents & Biologic therapy
26 Jul 2016 Press Release: ESMO Publishes Results of European Consortium Study on the Availability of Anti-neoplastic Medicines
25 Jul 2016 EMA Recommends Extension of Therapeutic Indications for Crizotinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Jul 2016 July 2016 – Image of the Month
22 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Cabozantinib in Advanced RCC Genitourinary cancers - Anticancer agents & Biologic therapy
21 Jul 2016 Press Release: ESMO 2018 Annual Congress to be Held in Munich
20 Jul 2016 PRAC Concludes Review of Idelalisib and Issues Updated Recommendations for Use Haematologic malignancies - Anticancer agents & Biologic therapy
18 Jul 2016 Acquired Resistance to PD-1 Blockade in Melanoma Translational research - Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
14 Jul 2016 FDA Approves First HPV Test for Use with SurePath Preservative Fluid Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies
13 Jul 2016 Statistical Perspective on Adaptive Strategy for Matching Targeted Therapies with the Patients Most Likely to Benefit Breast cancer - Anticancer agents & Biologic therapy
12 Jul 2016 Biomarker Tests for Molecularly Targeted Therapies Personalised medicine - Bioethics, legal and economic issues
11 Jul 2016 FDA Advances Precision Medicine Initiative by Issuing Two Draft Guidances on NGS-Based Tests Personalised medicine - Bioethics, legal and economic issues
07 Jul 2016 Press Release: Results of First Study Assessing Clinical Impact of ESMO-MCBS
07 Jul 2016 NICE Issues Quality Standard on Suspected Cancer Epidemiology/Etiology/Cancer Prevention - Diagnosis, Imaging and Staging